studi
aim
investig
efficaci
chitosan
oligosaccharid
administr
differ
dose
experiment
infect
lamb
cryptosporidium
parvum
male
lamb
use
studi
lamb
divid
group
lamb
group
group
twice
day
administ
chitosan
oligosaccharid
dose
mgkg
day
respect
milk
replac
group
lamb
cryptosporidiosi
subject
normal
feed
control
without
drug
administr
clinic
examin
lamb
made
treatment
day
day
treatment
ml
blood
collect
vena
jugulari
blood
analysi
lamb
weight
chang
lamb
record
day
stool
specimen
collect
pretreat
day
day
posttreat
determin
oocyst
excret
lamb
cryptosporidiosi
lamb
mean
oocyt
count
stool
examin
includ
treatment
chang
clinic
hematolog
blood
gase
biochem
paramet
observ
cours
treatment
chang
limit
weight
loss
observ
day
accord
day
lamb
experiment
cryptosporidiosi
gradual
weight
increas
observ
day
chang
similar
group
oocyst
excret
decreas
group
treatment
accord
day
signific
p
decreas
oocyt
excret
third
day
group
day
group
signific
chang
p
observ
oocyst
excret
third
fifth
day
among
group
result
lamb
experiment
cryptosporidiosi
chitosan
oligosaccharid
improv
clinic
sign
stool
charact
shorter
posit
control
group
administr
chitosan
oligosaccharid
dose
mgkg
day
significantli
reduc
oocyst
excret
enough
remov
cryptosporidiosi
complet
infect
caus
cryptosporidium
parvum
common
among
young
rumin
seen
variou
mammalian
includ
human
diseas
high
preval
across
world
among
import
caus
diarrhea
neonat
farm
anim
scott
paraud
chartier
constabl
et
al
c
parvum
one
primari
caus
diarrhea
seen
young
lamb
goat
diarrhea
develop
result
c
parvum
infect
alon
howev
mostli
develop
due
mix
infect
infect
occur
sever
diarrhea
outbreak
caus
high
mortal
lamb
age
day
zorana
et
al
goma
et
al
paraud
chartier
constabl
et
al
specif
treatment
cryptosporidiosi
report
paromomycin
lasalocid
halofuginon
lactat
sulfoxinoxalin
azithromycin
toltrazuril
partial
demonstr
effect
neonat
rumin
cryptosporidiosi
viu
et
al
wright
coop
giadini
et
al
navarr
et
al
yagci
et
al
aydogdu
et
al
chitosan
natur
polysaccharid
produc
deacetyl
chitin
nontox
biocompat
biodegrad
huang
et
al
zhao
et
al
chitin
main
compon
crustacean
crab
shrimp
etc
also
found
skeleton
insect
cell
wall
fungi
mani
deriv
chitin
import
one
chitosan
kumar
chitosan
chitosan
oligosaccharid
co
import
use
medic
field
control
drug
releas
artifici
blood
vessel
antidiabet
antibacteri
antifung
hemostat
effect
baldrick
xia
et
al
muanprasat
chatsudthipong
studi
treatment
calv
diarrhea
oral
chitosan
oligosaccharid
administr
report
success
treatment
alam
et
al
studi
conduct
chitosan
report
inhibit
vitro
develop
c
parvum
luzardo
et
al
adjou
et
al
mammeri
et
al
studi
found
efficaci
chitosan
oligosaccharid
treatment
cryptosporidiosi
neonat
rumin
determin
accord
inform
studi
first
determin
efficaci
chitosan
oligosaccharid
treatment
cryptosporidiosi
lamb
consid
chitosan
inhibit
develop
c
parvum
vitro
studi
hypothes
oral
chitosan
administr
may
use
treatment
lamb
experiment
cryptosporidiosi
aim
studi
determin
treatment
efficaci
oral
chitosan
oligosaccharid
lamb
experiment
cryptosporidiosi
ethic
committe
approv
project
taken
siva
cumhuriyet
univers
anim
experi
local
ethic
committe
studi
conduct
experiment
procedur
start
simultan
group
studi
total
male
lamb
younger
day
age
lamb
everi
group
use
stool
specimen
lamb
collect
test
use
rapid
pensid
test
biox
diagnost
sa
belgium
term
cryptosporidium
parvum
rotaviru
escherichia
e
coli
clostridium
perfringen
stain
stool
sampl
also
examin
cryptosporidium
detect
posit
one
exclud
studi
prevent
contact
lamb
hous
separ
individu
compart
c
parvum
oocyst
need
format
infect
obtain
rectal
stool
sampl
taken
natur
infect
calv
diarrhea
stool
sampl
calv
examin
use
rapid
pensid
test
biox
diagnost
sa
belgium
term
presenc
rotaviru
coronaviru
e
coli
neg
one
use
oocyst
requir
infect
format
obtain
report
studi
conduct
goat
kid
koudela
jiri
format
infect
lamb
ml
distil
water
contain
c
parvum
oocyst
given
use
intraor
cathet
nasogastr
cathet
ch
mm
bicakcilar
co
ltd
istanbul
turkey
develop
infect
monitor
collect
rectal
stool
sampl
daili
microscop
examin
stain
prepar
stain
prepar
stool
sampl
made
accord
koudela
jiri
lamb
averag
oocyst
stain
stool
prepar
consid
infect
treatment
initi
infect
develop
follow
treatment
protocol
appli
group
includ
lamb
oocyst
shed
start
lamb
day
reach
peak
level
day
treatment
procedur
dose
mgkg
chitosan
oligosaccharid
given
lamb
group
interv
h
drug
given
infect
lamb
group
fed
normal
posit
control
consid
dehydr
degre
blood
ga
analysi
find
requir
fluid
treatment
given
lamb
diarrhea
caus
dehydr
develop
oral
fluid
treatment
appli
lamb
mild
moder
dehydr
metabol
acidosi
ph
intraven
mlkghour
isoton
sodium
bicarbon
appli
lamb
sever
dehydr
metabol
acidosi
ph
dextros
appli
case
hypoglycemia
studi
lamb
fed
lamb
food
optimilk
optima
kirklar
turkey
amount
bodi
weight
proper
temperatur
two
meal
addit
adlibitum
water
provid
lamb
studi
watersolubl
chitosan
oligosaccharid
deacetyl
degre
molecular
weight
dalton
use
treatment
materi
glycobio
compani
dalian
china
routin
clinic
examin
lamb
bodi
temperatur
heart
frequenc
respiratori
rate
capillari
refil
time
assess
dehydr
degre
conduct
treatment
day
day
treatment
treatment
lamb
examin
daili
clinic
term
stool
analysi
collect
blood
sampl
analys
ml
blood
sampl
collect
lamb
treatment
day
day
treatment
blood
ga
analysi
hematolog
analys
k
edta
tube
biochem
analys
ml
anticoagul
free
gel
tube
blood
hydrogen
ion
concentr
ph
partial
carbon
dioxid
pressur
pco
partial
oxygen
pressur
po
bicarbon
hco
total
carbon
dioxid
tco
base
excess
oxygen
satur
sat
glucos
lactat
level
measur
use
blood
ga
analyz
epoc
canada
immedi
blood
sampl
collect
without
ad
anticoagul
agent
use
blood
sampl
collect
k
edta
tube
white
blood
cell
wbc
red
blood
cell
rbc
hemoglobin
hgb
hematocrit
hct
mean
corpuscular
volum
mcv
mean
cell
hemoglobin
concentr
mchc
red
cell
distribut
width
rdw
platelet
plt
valu
determin
automat
cell
counter
mindray
china
hematolog
analys
conduct
within
min
blood
collect
tube
without
anticoagul
kept
room
temperatur
clot
centrifug
rpm
min
obtain
serum
serum
sampl
store
analysi
urea
creatinin
total
protein
albumin
aspart
aminotransferas
ast
gammaglutamyltransferas
ggt
alkalin
phosphatas
alp
level
serum
sampl
determin
use
autoanalyz
bs
mindray
china
stool
sampl
lamb
collect
rectum
steril
stool
contain
treatment
day
day
treatment
stool
sampl
evalu
term
physic
normal
solid
loos
formless
semifluid
wateri
oocyst
presenc
c
parvum
oocyst
stool
determin
use
kinyoun
acidfast
stain
method
korkmaz
ok
stain
prepar
examin
use
immers
oil
magnif
light
microscop
concentr
c
parvum
oocyst
stool
averag
count
oocyst
differ
microscop
field
prepar
semiquantit
score
made
follow
absenc
oocyst
oocyst
oocyst
oocyst
lamb
mean
number
oocyst
includ
studi
koudela
jiri
examin
stool
sampl
made
personnel
lamb
weigh
use
digit
scale
treatment
day
posttreat
day
weight
chang
record
data
express
mean
standard
error
mean
sem
kolmogorovsmirnov
test
use
normal
oneway
anova
tukey
multipl
rang
test
use
evalu
differ
treatment
group
experi
signific
level
variat
statist
signific
level
accept
p
spss
softwar
program
version
spss
inc
chicago
il
usa
use
statist
analysi
oral
administr
oocyst
day
observ
chang
characterist
stool
decreas
stool
consist
oocyst
excret
start
presenc
mucu
oral
administr
oocyst
lamb
day
diarrhea
rang
pasti
liquid
consist
contain
high
number
oocyst
observ
lamb
suitabl
experiment
procedur
taken
treatment
protocol
infect
occur
lamb
group
experiment
procedur
appli
lamb
n
stool
mucu
observ
lamb
group
respect
intens
oocyst
began
excret
stool
yellowgreenish
color
sometim
brown
color
condens
mucu
appear
blood
observ
stool
death
group
day
howev
lamb
group
die
day
lamb
day
lamb
die
group
condens
mucu
liquid
diarrhea
dehydr
observ
lamb
inappet
abdomin
distens
sever
diarrhea
hypoglycemia
observ
last
day
dead
lamb
lamb
respond
fluid
treatment
applic
die
lamb
develop
cryptosporidiosi
gener
dynam
appear
normal
mucosa
good
suck
reflex
howev
depress
reluct
stand
dehydr
max
level
prolong
capillari
refil
time
decreas
suck
reflex
observ
lamb
dehydr
occur
lamb
maximum
level
chang
bodi
temperatur
heart
respiratori
frequenc
lamb
present
tabl
bodi
temperatur
lamb
observ
rang
signific
differ
p
observ
day
group
term
bodi
temperatur
signific
differ
found
day
moreov
bodi
temperatur
lamb
decreas
group
compar
day
decreas
statist
signific
except
group
p
signific
differ
found
day
group
term
respiratori
frequenc
p
chang
oocyst
excret
lamb
treatment
day
posttreat
day
given
tabl
found
oocyst
excret
group
significantli
decreas
day
compar
day
p
hand
found
oocyst
excret
group
significantli
decreas
day
compar
day
p
group
signific
decreas
observ
group
day
group
day
compar
group
p
bodi
weight
measur
lamb
perform
treatment
day
posttreat
day
chang
bodi
weight
lamb
day
given
tabl
found
lamb
group
weight
loss
day
gradual
increas
weight
day
signific
differ
observ
group
term
weight
chang
lamb
ingroup
differ
day
examin
signific
differ
found
group
except
third
group
p
blood
ga
analysi
result
lamb
treatment
day
given
tabl
group
mean
blood
ph
within
normal
rang
treatment
ingroup
statist
signific
chang
blood
ph
day
howev
statist
signific
differ
group
day
p
metabol
acidosi
observ
case
group
day
case
group
day
case
group
day
case
group
day
pco
level
similar
group
increas
decreas
observ
ingroup
day
howev
increas
decreas
statist
signific
group
p
blood
po
sat
level
show
signific
chang
group
ingroup
day
lactat
level
group
significantli
higher
group
day
lactat
level
group
significantli
higher
group
group
second
day
increas
decreas
lactat
level
ingroup
day
statist
signific
differ
observ
group
p
increas
decreas
hco
tco
level
lamb
treatment
howev
chang
signific
affect
ph
differ
hco
tco
level
ingroup
day
signific
p
group
signific
differ
determin
group
term
hco
tco
level
day
p
chang
hematolog
paramet
lamb
day
treatment
given
tabl
although
increas
decreas
hematolog
paramet
ingroup
day
statist
signific
differ
found
signific
p
differ
wbc
level
day
group
signific
differ
found
day
similar
group
term
rbc
hgb
hct
mchc
plt
level
addit
group
mcv
level
differ
statist
signific
level
day
rdw
level
day
p
chang
biochem
paramet
lamb
day
treatment
given
tabl
ast
level
lamb
increas
treatment
compar
pretreat
day
alp
tp
ggt
level
decreas
howev
chang
ast
alp
activ
group
chang
total
protein
level
group
statist
signific
p
increas
decreas
urea
creatinin
level
group
day
chang
creatinin
level
group
signific
p
glucos
level
group
examin
day
glucos
level
group
decreas
day
compar
day
increas
follow
day
glucos
level
group
decreas
day
compar
day
increas
gradual
follow
day
statist
signific
determin
group
p
signific
differ
p
group
determin
tp
creatinin
level
day
major
problem
cryptosporidiosi
lack
effect
tool
prevent
treatment
diseas
substanc
test
treat
cryptosporidiosi
dinler
uluta
shown
promis
effect
howev
none
report
control
clinic
find
consist
elimin
infect
complet
hand
use
certain
drug
may
reduc
oocyst
excret
thu
probabl
environment
pathogen
level
subsequ
exposur
infect
suscept
host
shahiduzzaman
daugschi
report
paromomycin
halofuginon
lactat
lasalocid
sulfaquinoxalin
partial
demonstr
effect
cryptosporidium
infect
neonat
rumin
wright
coop
aydogdu
et
al
howev
knowledg
treatment
cryptosporidiosi
sheep
limit
halofuginon
exhibit
toxic
recommend
dose
lactat
use
contraind
sever
dehydr
inappet
anim
wright
coop
addit
mani
drug
paromomycin
azithromycin
sulfaquinoxalin
determin
reduc
oocyst
excret
cryptosporidiosi
risk
leav
antibiot
residu
recent
year
seriou
concern
antibiot
residu
emerg
worldwid
recent
year
studi
carri
effect
chitosan
deriv
underli
mechan
antimicrobi
activ
chitosan
microparticl
medic
field
treatment
infecti
diseas
jeon
et
al
kim
et
al
report
oral
chitosan
oligosaccharid
applic
dose
mgkgday
caus
side
effect
differ
letter
row
b
column
b
statist
signific
p
group
mgkg
co
group
mgkg
co
group
mgkg
co
interv
h
group
drug
given
infect
lamb
b
c
differ
letter
row
b
c
e
column
b
statist
signific
p
group
mgkg
co
group
mgkg
co
group
mgkg
co
interv
h
group
drug
given
infect
lamb
rat
studi
conduct
protect
activ
chitosan
oligosaccharid
determin
mice
coliti
form
experiment
yousef
et
al
chung
et
al
found
oral
administ
chitosan
oligosaccharid
low
molecular
weight
reduc
allerg
inflamm
mice
experiment
asthma
model
form
abdellatif
et
al
report
anticoccidi
effect
eimeria
papillatainfect
mice
studi
report
excret
oocyst
development
stage
parasit
reduc
chitosan
antiinflammatori
activ
abdellatif
et
al
studi
oral
chitosan
oligosaccharid
administ
treatment
diarrheal
calv
report
success
alam
et
al
addit
chitosan
use
creat
excipi
microparticl
system
report
might
play
role
physic
barrier
cryptosporidium
parvum
et
al
studi
conduct
report
inhibit
vitro
develop
c
parvum
luzardo
et
al
adjou
et
al
mammeri
et
al
addit
mammeri
et
al
report
chitosan
nag
chitosan
mix
demonstr
vivo
anticryptosporidi
properti
mice
highli
sensit
anim
model
c
parvum
infect
therefor
state
compound
promis
potenti
therapeut
prevent
applic
c
parvum
infect
studi
oocyst
excret
decreas
significantli
p
group
day
compar
pretreat
group
day
group
signific
decreas
observ
group
day
group
day
compar
group
p
although
stool
characterist
becam
normal
st
day
observ
oocyst
excret
still
continu
lamb
lamb
posit
control
group
oocyst
excret
level
day
level
found
lower
treatment
group
compar
posit
control
group
howev
statist
differ
found
result
show
chitosan
oligosaccharid
significantli
reduc
oocyst
excret
compar
posit
control
group
howev
efficaci
elimin
cryptosporidiosi
complet
accord
find
studi
use
chitosan
oligosaccharid
use
treatment
experiment
cryptosporidiosi
dose
andor
mgkg
found
provid
earlier
reduct
oocyst
excret
compar
mgkg
dose
use
higher
dose
neg
effect
howev
increas
cost
show
posit
affect
compar
lower
dose
consid
dose
mgkg
thought
appropri
dose
result
indic
low
dose
chitosan
oligosaccharid
better
reduc
oocyst
excret
improv
clinic
find
lamb
cryptosporidiosi
studi
ph
concentr
hydrogen
ion
pco
partial
pressur
carbon
dioxid
po
partial
pressur
oxygen
hco
bicarbon
tco
total
amount
carbon
dioxid
base
excess
sat
oxygen
satur
differ
letter
row
b
column
b
statist
signific
p
group
mgkg
co
group
mgkg
co
group
mgkg
co
interv
h
group
drug
given
infect
lamb
mammeri
et
al
exact
mechan
action
chitosan
continu
report
possibl
chitosan
caus
effect
product
trophozoit
oocyst
via
variou
mechan
direct
effect
parasit
viabil
andor
infect
andor
parasit
growth
intestin
andor
oocyst
format
mammeri
et
al
howev
studi
requir
determin
exact
mechan
action
limit
studi
absenc
neg
control
group
without
infect
treatment
absenc
group
treat
co
without
cryptosporidiosi
infect
gener
mix
infect
clinic
find
cryptosporidiosi
sever
transient
mild
level
mix
infect
clinic
find
sever
mortal
rate
higher
morbid
rate
high
mortal
low
cryptosporidiosi
infect
alon
constabl
et
al
studi
observ
chang
clinic
find
sever
group
howev
individu
differ
characterist
diarrhea
improv
day
day
treatment
group
posit
control
group
treatment
group
stool
becam
normal
pasti
consist
day
still
diarrhea
liquid
level
case
posit
control
group
day
result
show
chitosan
oligosaccharid
provid
faster
recoveri
clinic
find
stool
characterist
lamb
cryptosporidiosi
compar
posit
control
group
import
clinic
find
cryptosporidiosi
diarrhea
vari
level
endogen
form
cryptosporidium
lead
loss
matur
enterocyt
shorten
fusion
villu
disrupt
microvilli
boundari
caus
elong
crypt
caus
increas
cell
divis
edema
caus
loss
membranebound
digest
enzym
reduc
intestin
absorpt
capac
reduc
intak
liquid
electrolyt
nutrient
intestin
lumen
foster
smith
constabl
et
al
studi
found
although
signific
ingroup
andor
intragroup
chang
observ
blood
gase
hematolog
biochem
paramet
treatment
group
posit
control
group
chang
remain
limit
progress
gener
within
refer
limit
metabol
acidosi
observ
case
group
day
case
group
day
case
group
day
case
group
day
howev
determin
metabol
acidosi
moder
sever
level
st
group
case
case
sever
metabol
acidosi
remain
mild
result
show
experiment
develop
cryptosporidiosi
alon
lamb
lead
chang
blood
gase
hematolog
biochem
paramet
howev
chang
level
disrupt
gener
condit
conclus
found
experiment
cryptosporidiosi
form
success
oral
inocul
solut
contain
oocyst
lamb
age
day
oral
administ
chitosan
oligosaccharid
lamb
dose
mg
kg
side
effect
chitosan
oligosaccharid
provid
faster
recoveri
clinic
find
stool
characterist
lamb
cryptosporidiosi
form
experiment
compar
posit
control
group
administ
chitosan
oligosaccharid
dose
mgkg
day
significantli
decreas
oocyst
excret
howev
effici
enough
complet
elimin
cryptosporidiosi
studi
appropri
chitosan
oligosaccharid
dose
treat
cryptosporidiosi
lamb
observ
mgkg
wherea
new
studi
subject
requir
think
studi
provid
basic
knowledg
studi
use
chitosan
deriv
treatment
cryptosporidiosi
veterinari
medicin
author
declar
conflict
interest
